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LINEAGE TRACING OF SKELETAL PROGENITOR CELLS DURING 
POSTNATAL BONE FORMATION 
 
ANDREW BENNIE 
ABSTRACT 
Introduction: Fractures represent a common orthopaedic injury and create a large 
financial burden for the health care system. Non-union fractures often require surgery to 
assist the healing process. Understanding the origin of the postnatal skeletal stem cells 
will allow for locally delivered therapeutic treatments to be more exactly spatially 
targeted for fracture healing. Two forms of post-natal bone formation were studied, callus 
formation after fracture and ectopic bone growth. Both forms of bone formation closely 
follow the mechanisms of endochondral ossification. The Prx1 gene that is known to be 
expressed by skeletal stem/progenitor cells within the periosteal tissues was used to 
spatially follow this cell population during ectopic and fracture induced bone formation.   
Objectives: The purpose of this study was to define the cell lineages that arise from Prx1 
expressing cells in fracture and ectopic bone models.  
Methods: Prx1 expressing cells were tracked using Prx1CreER-GFP x RosaAi14 
(dTomato indicator) and Prx1CreER-GFP x Ai14i (dTomato indicator) in the Rag1tm 
strain of transgenic mice. These mice strains respectively received a closed stabilized 
fracture or human demineralized bone matrix (DBM) that was surgically implanted onto 
the periosteal surface of the femur to initiate the development of ectopic bone. Tissue was 
collected at either day 10 or 14 post-fracture surgery or day 8 post-DBM implantation. 
Prx1CreER-GFP expression was induced by tamoxifen or control animals received no 
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injection or corn oil. Three different tamoxifen induction protocols (30 days prior to 
surgery to allow for washout, three days prior to, or continuously after either fracture or 
ectopic bone induction were used. Fluorescent microscopy of the histological images 
were performed to assess the cell populations that expressed Prx1 and cell counting was 
used to quantify the percentages of Prx1 positive cells in specific regions of interest. 
qRT-PCR of Prx-1 mRNA expression was used to provide the relative gene expression of 
Prx1 in a variety of different tissues.  
Results: Control animals that received corn oil or no Tamoxifen showed low levels (~5-
15%) labeled cells, however there was a ~2 fold increase in labeling with Tamoxifen 
washout. Labeled cells were present within calvaria, femur, tibia, and forelimb bones, 
while very low amounts were located at the sternum rib junction but were absent in the 
vertebra. Up to 55-65% of the cells within fracture callus and ectopic bone models 
showed Prx1 labeled in both cartilage and bone cells. Most interestingly however was the 
increased presence of Prx1 positive cells throughout the skeletal muscle, growth plate, 
medial layers of blood vessels, and adipose tissue of appendiculum. Labeling was not in 
muscles of the chest and back.  Upon investigation of several different organs very low 
levels of Prx1 positive cells in the kidney, aorta and brain.. However, no Prx1 cells were 
located in the heart, spleen or liver tissues.  
Conclusions: While a population of Prx1 cells was shown previously to be localized to 
the periosteum and contribute to fracture repair this study showed these cells in multiple 
tissue types throughout the appendiculum. Our results are the first in vivo demonstration 
to suggest that there is a multi-potential post natal mesenchymal stem population. This 
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Prx1 positive cell population was not seen in ectopic bone that was induced outside the 
appendiculum indicating that these cells retained their original embryonic specification 
into the adult animal.  
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INTRODUCTION 	 Research in the field of orthopaedics often focuses on bone formation, growth, 
and repair mechanisms. In the United States alone, approximately 6.3 million fractures 
occur annually according to the National Hospital Ambulatory Medical Care Survey and 
the American Academy of Orthopaedic Surgeons. This leads to an estimated annual cost 
of $20 billion to the United States healthcare system (Cherry et al., 2008).  
  Complications can arise during bone healing and repair. A common problem, 
nonunion, occurs when the fracture fails to heal properly. This can be due to a multitude 
of different risk factors including diabetes, cigarette smoking, or even the location of the 
fracture. Sometimes, surgical intervention is required and may encompass bone grafting 
to stimulate the bone healing process (Dahabreh et al., 2007). A more comprehensive 
understanding of the mechanisms driving post-natal bone formation, may lead to 
potential therapeutic options. 
Bone Development (Endochondral and Intramembranous Ossification) 
 Bone formation is accomplished via one of two processes: endochondral 
ossification or intramembranous ossification. During embryogenesis, the skull and flat 
bones form by intramembranous ossification where mesenchymal cells proliferate, 
condense, and differentiate to osteoblasts, the bone forming cells. As shown in figure 1, 
these osteoblasts secrete osteoid matrix, which is made of type I collagen and 
proteoglycan. This matrix can then bind calcium and phosphate salts to form new 
mineralized bone. Sometimes, osteoblasts are caught within the matrix and become 
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trapped. These embedded cells are called osteocytes, an important regulator of bone and 
nutrient/waste exchange (Gilbert, 2000).  
 
 
 
 
 
 
 
 
 
 
Endochondral ossification is responsible for the remainder of the developing bones. To 
begin, the Shh protein, leads to the induction of mesodermal cells to express transcription 
factors, including Pax1 and Scleraxis, that ultimately allows for the activation of cartilage 
specific genes (Gilbert, 2000). The mesenchymal cells express N-cadherin leading to 
condensation and differentiate into chondrocytes. (Oberlender and Tuan, 1994). Even 
before condensation, within these cells Sox9 is expressed and thought to be a key 
transcription factor for specifying the osteochondral lineage (Wright et al., 1995). The 
chondrocytes proliferate to form a model of the future bone. During this process, an 
extra-cellular matrix rich in cartilage made of proteoglycans, glycosaminoglycans, and 
mainly type II collagen, is secreted by the dividing chondrocytes (Gilbert, 2000).  
Figure 1: Intramembranous Ossification. This image 
reveals the different components present during 
intramembranous ossification and their relationship to each 
other. Figure taken from Gilbert, 2000.  	
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The chondrocytes then grow dramatically and become hypertrophic. At this point, blood 
vessel invasion occurs by hypertrophic chondrocytes expressing VEGF and recruitment 
of osteoprogenitor cells. The extra-cellular matrix is altered by the addition of collagen X 
and largely Type I collagen fibers allowing for osteoblasts, to secrete osteoid and produce 
bone tissue by using the cartilage scaffold (Mackie et al., 2008).  
 
Chondrocytes become apoptotic leaving a gap that will eventually become the bone 
marrow space and there is also support claiming that a few of these chondrocytes can 
further differentiate into osteoblast like cells. (Yang et al., 2014). 
Following endochondral ossification, continued longitudinal bone growth is 
exhibited within the epiphyseal growth plate. Here, chondrocytes exist in three stages of 
development. The outermost region houses the resting chondrocytes, responsible for 
continually renewing the process. The next section contains proliferating chondrocytes, 
waiting to enter the next stage of hypertrophy. As the inner layer of chondrocytes 
Figure 2: Endochondral Ossification. This figure illustrates the stages of endochondral 
ossification with important markers identified. Figure taken from Gilbert, 2000.  	
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hypertrophies it secretes extra-cellular matrix, which is to be eventually replaced by bone 
matrix to be mineralized. (Mackie et al., 2008).  
Post-Natal Bone Formation 
Fracture Healing Cascade 
Fracture healing has been demonstrated to follow endochondral ossification seen 
during embryogenesis (Einhorn and Gerstenfeld, 2014). The scheme of fracture healing 
can be generalized to four stages. To begin, the initial trauma creating the fracture leads 
to a local inflammatory response in the surrounding tissue.  Following this, a hematoma 
will develop in the presence of bleeding near the fracture site. With the formation of a 
hematoma, many inflammatory cells, cytokines, and growth factors are released. 
Specifically, bone morphogenic proteins, interleukins 1 and 6, as well as TNF-	α, are 
essential in recruiting the appropriate skeletal progenitor cells to assist in callus 
formation.  
 
 
 
 
 
 
 
 
 
Figure 3: Fracture Healing Cascade. This image represents the 
stages involved in fracture healing with magnified detail to expose 
crucial steps in each phase. Figure taken from Einhorn and 
Gerstenfeld, 2014.  	
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It is believed that these progenitor cells originate from sites including the 
periosteum, bone marrow, as well as nearby adipose and muscle tissue, then differentiate 
into both fibroblasts and chondrocytes (Phillips, 2005). As demonstrated by figure 3, 
fibroblast and chondrocyte proliferation initiates the formation of what is defined as the 
soft callus. This soft callus acts as a bridge to connect the two ends of the fractured bone. 
From here, the remainder of the process closely mimics that of endochondral ossification. 
The chondrocytes become hypertrophic and mineralize the cartilage prior to death via 
apoptosis. It has been demonstrated that some chondrocytes can transdifferentiate into 
osteoblasts to help create new bone (Zhou et al., 2014). Transformation between the soft 
and hard callus is notable for the increased osteoblast activity, working to produce new 
fibrous bone (Einhorn and Gerstenfeld, 2014). The final step in fracture healing involves 
the combination of osteoclasts removing that initial woven bone with osteoblasts 
following to help produce the final product, lamellar bone.  
Ectopic Bone Formation 
 
 The emergence of ectopic bone within soft tissue has also been demonstrated to 
imitate endochondral ossification. Within a demineralized bone matrix scaffold, the 
process differs in that the cartilage is ossified after resorption of the cartilage, rather than 
simultaneously as described in long bone formation. Following total hip replacements, a 
common complication arises with heterotopic ossification within the nearby soft tissue 
(Amar et al., 2015). This can have a major impact on the functional outcome of the 
surgery and often leads to pain and decreased range of hip motion for patients. In severe 
	6 
cases, surgical excision of the ectopic bone is required to improve the quality of life for 
patients.  
 Demineralized Bone Matrix obtains its osteo-inductive attributes from the 
presence of BMPs, bone morphogenetic proteins. These BMPs work to mobilize 
mesenchymal stem cells to the matrix. An environment rich in type I collagen adds the 
osteo-conductive component necessary to prepare for bone formation (Bauer and 
Muschler, 2000). Implantation of DBM within muscle at many different sites, against the 
periosteum and under the kidney capsule has been shown to induce ectopic bone 
formation as well, and is used in our studies as a means to form this tissue (Kurkalli et al., 
2010).  
Stem Cells 
 Stem cells are defined by two key characteristics, 1) as having the capacity to 
remain undifferentiated while being able to differentiate at some future time point and 2) 
self-renewal (Pittenger et al., 1999). The expression of Pax7, Prx1, and Gremlin have 
been identified as markers for osteogenic stem cells (Seale et al., 2000 and Hu et al., 
2017). 
 A member of the paired-homeobox gene family, Prx1 is mainly found in the 
mesoderm with expression relatively specific to limb buds (Logan et al., 2002). It has 
been demonstrated that Prx1 acts as a transcription co-activator, which increases DNA 
binding specificity within bone in an attempt to regulate both chondrocyte differentiation 
and proliferation (Mitchell et al., 2006). Expressed in both chondrogenic and osteogenic 
lineages, Prx1 has been previously found within the callus during fracture healing (Murao 
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et al., 2013). Prx1 cells from the surrounding skeletal muscle and periosteal surface are 
recruited to the site of the fracture during the inflammatory portion of the process in order 
to assist in the regulation of bone repair (Abou-Khalil et al., 2015).  
Ectopic bone formation and fracture healing both closely resemble endochondral 
ossification. This study is interested in examining the differences in the amount of Prx1 
positive cells present within each sample of post-natal bone. By tracking the Prx1 
positive cells, the role that Prx1 plays in post-natal endochondral osteogenesis can be 
more fully understood.  
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	8 
SPECIFIC AIMS 
 
Aim 1.  Determine the sensitivity of the Cre recombinase system by evaluating the 
presence of Prx1 cells in control samples. 
Aim 2.  Investigate the Prx1 lineage of cells present in a fracture callus at different post-
operative time points. 
Aim 3. Explore the role of Prx1 expressing stem cells/progenitors in DBM induced 
ectopic bone produce when implanted on periosteal surface. 																				
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METHODS 
 
Animals 
 The Institutional Animal Care and Use Committee at Boston University approved 
all animal studies performed. Prx1CreER-GFP transgenic mice were acquired from Dr. 
Shunichi Murakami from Case Western Reserve University and have been described by 
(Kawanami et al., 2009). These mice were crossed with 129S4-Gt(Rosa)26 Ai14 reporter 
mice from Jackson Laboratories (Bar Harbor, Maine) to produce a Prx1CreER-GFP-
RosaAi14 offspring. In addition the Prx1CreER-GFP mice were also bred with B6-
129S7Rag1tm mice from Jackson Laboratories to create a Prx1CreER-GFP-Ai14iRag1tm 
strain. These new transgenic mouse strains were housed in standard conditions at the 
BUSM animal facility. In total, 29 mice were utilized throughout the study.  
Surgery Preparation 
 Experimental mice were first anesthetized using a combination of 4% isofluorane 
and oxygen in an anesthesia chamber. Once the mouse was anesthetized, it was moved to 
a nose cone with continued 2% isofluorane and oxygen to maintain sedation. Prior to 
aseptic surgery, the mice received subcutaneous injections of 0.1 mL Buprenex® at 
0.3mg/mL for pain control and 0.01 mL 2.27% Baytril® for antibiotic coverage. The 
surgical site was prepped by shaving and cleaning the area with Betadine.  
Fracture Surgery 
Fracture was performed as previously described (De Giacomo et al., 2014). 
Briefly, the right distal femur was exposed by bending the knee and making a medial 
incision allowing movement of the patella. By inserting a U-100 27 gauge insulin syringe 
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into the femur, a hole was produced in the femoral condyle. A stylet from a 25 gauge 
spinal needle was placed into the reaming to act as an intra-medullary pin. This needle 
was cut at the distal end with wire cutters and buried using forceps. After straightening 
the right leg to assess proper intra-medullary pin placement, 5-0 USP Perma Sharp 
sutures were used to close the wound. This mouse was then moved to a modified three 
point bending fracture device (Bonnarens et al., 1984). There, the leg was straightened 
over the impact area and a blunt blade was dropped, landing over the mid-diaphyseal 
shaft of the right femur to produce a closed transverse fracture. To assess the fracture and 
placement, an X-ray (Kodak Ultra Speed DF-50, Size 4) was taken using a dental X-ray 
machine with settings of 70 kV and 0.10 seconds. Weight was recorded and the mouse 
was allowed to recover over a heating pad before placing into cage.   
DBM Surgery 
Using a number 15 scalpel blade, an incision was initiated at the greater 
trochanter of the proximal femur and was extended 1.5 cm distally toward the knee. The 
fascial plane was cut and the muscle was bluntly dissected from the femur. 
Approximately 50 mg of Grafton DBM Putty was implanted on the femoral surface of the 
femur. The fascia was closed with 6-0 USP Perma Sharp sutures and using 5-0 USP 
Perma Sharp sutures the overlying dermis was closed.  Similar to the fracture surgery, the 
experimental mouse was monitored on a heating pad at medium heat. 
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X-rays 
Fractured femurs were visualized via X-ray on two occasions. Shown in figure 4, 
post-fracture X-rays were obtained to confirm the presence of a fracture and evaluate the 
position of the intra-medullary pin. 
 
 
 
 
 
 
 
In addition, the mice that undergo the fracture surgery are imaged again during the 
harvest of the tissues to identify the presence of callus formation around the fracture site. 
Below, figure 5 displays X-rays taken at harvest, revealing of ectopic bone either through 
the formation of a callus around the proximal fracture or with a periosteal implant.	
 
 
 
 
 
 
 
Figure 4: Post-Fracture X-rays. These X-rays completed immediately after the fracture 
surgery help determine the presence and stability of the femoral fracture. 	
Figure 5: Post- Harvest X-rays. This figure represents the development of ectopic bone via 
callus formation at POD10 (A) and through periosteal DBM implant at POD 31(B).	
Callus 
Implant A B 
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Tamoxifen 
 Tamoxifen injections were used to induce the conditional Cre recombinase to 
relocate to the nucleus and therefore express dTomato. The tamoxifen 10 mg/mL solution 
was prepared by combining 10 mL corn oil with 100 mg Tamoxifen in a fume hood. To 
fully dissolve the tamoxifen in the corn oil, the solution was sonicated for 30 minutes, in 
cycles that included 3 minutes on and then 30 seconds off. The sonication was repeated 
until the tamoxifen powder was completely dissolved. The solution was then sterilized 
via a 0.22 micron sterile syringe filter and aliquoted into 2 mL sterile freezing vials.  
 
 
 
 
 
 
 
 
 
These were stored at -80˚C and then thawed for injections. Experimental mice received 
intra-peritoneal (IP) injections at 10 µL/g of their body weight. Control mice received 
intra-peritoneal injections of sterile corn oil at the same volume of 10 µL/g of their body 
weight and using the same injection schedule as tamoxifen (figure 6).  
 
Figure 6. Injection schedule. This image reveals the 
timeline that samples were injected. 
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Harvest 
 Mice were euthanized via carbon dioxide inhalation in a euthanasia chamber. 
Once the mouse was euthanized, a secondary measure of cervical dislocation was 
applied. Harvest weight was recorded prior to harvesting tissue. A post-mortem x-ray was 
performed in order to confirm the presence of a callus in fracture mice and the extent of 
ectopic bone development in the DBM implant mice. The x-ray was taken using Faxitron 
MX-20 Specimen Radiography System with the settings at 30 kV for 40 seconds. Film 
used for this x-ray was Kodak Biomax XAR Scientific Imaging Film. From there, the 
desired tissues were harvested fixed with 4% paraformaldehyde (PFA) at 4˚C.   
4% Paraformaldehyde  
 Under a fume hood, 100 mL 1x PBS was heated. Then, 4 g PFA was measured 
and added to the warm PBS. Drop by drop, 10N sodium hydroxide (NaOH) was added to 
the solution until it became clear. The solution was then removed from the heat and 
allowed to cool to room temperature. The solution pH was adjusted to 7.4 using either 
NaOH or hydrochloric acid (HCl). The 4% PFA was aliquoted into 15 mL tubes and 
stored at -80˚C.  
Decalcification 
 Bones were decalcified in 14% EDTA weight to volume deionized water solution. 
The pH was adjusted with NaOH to a range between 7.2 and 7.4. Samples were fixed for 
48 - 72 hours followed by decalcification at 4˚C. Samples were washed three times with 
1X PBS, then placed into labeled mesh bags and sealed with staples. To decalcify the 
samples, the sample were immersed in 14% EDTA in an aluminum foil covered jar to 
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prevent damage to the light sensitive tissue. A stirring bar was added and the jar was 
placed onto a stir plate for approximately 1 week.  
Embedding Preparation and Embedding 
 Using a U-100 27 gauge insulin syringe, the samples were probed to confirm that 
the bone had been decalcified and was ready to be embedded. These samples were again 
washed several times in 1X PBS. Then while on ice, samples were washed in 7.5% 
sucrose in PBS twice over a one-hour time period. Once completed, the samples were 
immersed in 30% sucrose in PBS and put onto a rotor at 4˚C overnight. The next day, 
samples were then placed into a 1:1 mixture of Optimal Cutting Temperature Compound 
(OCT): 30% Sucrose in PBS. These samples again were placed back onto the rotor 
overnight.  
 To set-up for freezing, liquid nitrogen was collected into two stainless steel 
dewars. A tripour beaker was immersed into the liquid nitrogen and tetrafluoroethane was 
condensed into the tripour beaker. The samples were placed into standard cryomolds and 
covered with OCT. These cryomolds were immersed into the liquid cooled 
tetrafluoroethane for 30 seconds to one minute until completely frozen. These frozen 
samples were then stored in -80˚C until sectioned.  
Histology 
 Sections (10µm) were cut on a cryostat and then submerged in 1X PBS for five 
minutes twice, and then rinsed several times in ddH20. The sections were allowed to air 
dry, then cover-slipped using Molecular Probes ProLong © Gold Antifade reagent with 
DAPI. Air bubbles were removed from the samples using a wooden applicator stick.  
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 Using the Olympus BX51 microscope and CellSens software, high resolution 
images were captured of the sample sections. Images were gathered at the following 
exposure times: approximately 335 ms for the DAPI filter and 86 ms for the dTomato 
filter. Slight adjustments to the exposure time were made on a sample-by-sample basis. 
Prior to imaging, calibrations including shading, stage limits, and white balance were 
conducted. Stitching together individual images at 10x formed overview images to 
evaluate the whole section. Specific sites of interest were captured at 20x magnification 
for further detail. Images were captured using the DAPI filter to identify nucleated cells 
and dTomato filter to identify Prx1 positive cells.  
 To count cells, the fracture callus was manually delineated by histological 
appearance into cartilage and ossifying bone tissues while the ectopic bone was separated 
from the surrounding skeletal muscle in the DBM implant samples. Utilizing the DAPI 
filter, a total number of nucleated cells within these areas was obtained. The same regions 
weer counted for fluorescently labeled cells using the dTomato filter to assess for the 
presence of Prx1 cells. The regions of interest were manually demarcated and a minimum 
object size of 20 pixels was set to ensure that only cells were being counted. The adaptive 
threshold varied depending on the image, but was usually set with a lower limit around 8 
and an upper limit of 186.  
Quantitative Real Time Polymerase Chain Reaction 
 For gene expression analysis, cDNA of various tissues from a previous study that 
had been performed in the laboratory was used. To begin, RNase free water was 
combined with the thawed cDNA to produce a 1:25 dilution of the cDNA. Next, 10 µL of 
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Taqman® Universal PCR Master Mix (Applied Biosystems®) was combined with 1 µL 
Taqman® Gene Expression Assays primer (Applied Biosystems®), either Prx1 or 18s. 
This 11µL mixture was added to the well of a 96 well PCR plate on ice. Nine microliters 
of the diluted cDNA was inserted into each well and samples were run as duplicates. The 
PCR plate was covered with a clear adhesive film and spun in a centrifuge at 1500 RPM. 
The qRT-PCR was completed via an ABI 7700 Sequence Detector® (Applied 
Biosystems®) with the following settings: 40 cycles of 50˚C for 2 minutes, 95˚C for 10 
minutes, 95˚C for 15 seconds, 60˚C for 1 minute.   
 We normalized Ct values to 18s rRNA and humerus tissue. The ΔΔCt method was 
used to show relative gene expression.  Using Microsoft Excel® 2013, the mRNA 
expression of Prx1 was graphed to appropriately display the presence of Prx1 cells within 
multiple tissues.  	
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RESULTS 
 The goal of this study was to identify a skeletal stem cell population using the 
Prx1 as a marker and trace the lineages into which these cells developed during postnatal 
endochondral bone formation induced by either fracture repair or ectopic bone formation. 
Prx1 Mouse Model 
The Prx1CreER-GFP-RosaAi14 mice used for this study allowed for both 
conditional and inducible control of the Cre recombinase activity. A 2.4 kb Prx1 
promoter drives the expression of Cre recombinase. When Tamoxifen is given, it binds to 
the modified estrogen receptor that is attached to Cre. This complex then translocates to 
the nucleus and initiates recombination (Logan et al., 2002) resulting in the  removal of 
the stop codon and allowing for the expression of dTomato gene (figure 7). 
 
 
 
 
 
  
 
 				
 
	Figure 7: Cre-Recombinase Model. This illustration demonstrates the inducible Cre-recombinase 
system based on the presence of Tamoxifen. Although the figure shows GFP, our system used dTomato. 
A. Without Tamoxifen, there is no expression of the given reporter gene due to inability to translocate to 
the nucleus for recombination. B. When given Tamoxifen, Cre is able to move to the nucleus and mediate 
the recombination of the LoxP sites, removing the stop codon and marking the cells with the reporter 
gene. Figure taken from Greco and Guo, 2010. 
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By restricting the translocation via Tamoxifen, the Prx1 cells can be identified and 
tracked throughout the process of bone regeneration, a method called “pulse and chase” 
(Liu et al., 2016).  
Baseline Response 
 In order to further understand the role of Prx1 progenitor cells in bone 
regeneration and repair, it is essential to determine the presence of Prx1 cells in a baseline 
situation where no trauma or other osteogenic factor has been introduced to the 
environment. To complete this, experimental mice were injected with Tamoxifen in 
different methods, including a “pulse and chase” format, “washout”, continuous mode 
throughout the period of tissue formation after induction, and no injections. The dTomato 
is identified as red in the fluorescent images supplied and represents the cells expressing 
Prx1. 
 
 																 Figure 8: 10x Stitched Overview Image - No Tamoxifen Injection 	
1mm	
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Figure 10: 10x Stitched Overview Image - Continuous Tamoxifen 
1mm	
Figure 9: 10x Stitched Overview Image - Tamoxifen Washout 	
1mm	
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Sterile corn oil injections were used as a control to compare with the Tamoxifen 
injections in an attempt to determine the “leakiness” of the Cre recombinase system. Two 
different strategies of injecting sterile corn oil were utilized: pulse and washout. 
Injections with the sterile corn oil were treated with the same method as the Tamoxifen 
injections to try to minimize potential confounding variables.		
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Figure 11: 10x Stitched Overview of Pulse Sterile Corn 
Oil. A: Right Femur. B: Left Femur. 	
1mm	
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Quantitative analysis was performed by counting the total number of cells within the 
femur and muscle. Table 1 below reveals the cell counts for total nucleated cells, Prx1 
cells, and then percentage of cells that are labeled Prx1 positive. Tamoxifen injections 
following a washout schedule displayed the largest percentage of Prx1 cells, followed by 
continuous Tamoxifen and lastly no Tamoxifen. For the sterile corn oil, the washout  
method again represented the largest share of Prx1 cells.  
 
 
 
 
 
Figure 12: 10x Stitched Overview of Washout Sterile Corn Oil.  	
1mm	
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Sample Bone Percentage 
of Prx1 Cells 
(%) 
Muscle Percentage 
of Prx1 
Cells (%) 
 Total 
Nucleated 
Cells 
Prx1 
Cells 
 Total 
Nucleated 
Cells 
Prx1 
Cells 
 
No 
Tamoxifen 
101,367 14,591 14.4% 59,340 2,507 4.2% 
Washout 
Tamoxifen 
104,812 22,213 21.2% 73,654 6,734 9.1% 
Continuous 
Tamoxifen 
92,890 17,278 18.6% 71,006 3,489 4.9% 
Pulse 
Sterile 
Corn Oil – 
Right 
Femur 
87,190 3,463 4.0% 68,175 1,904 2.8% 
Pulse 
Sterile 
Corn Oil – 
Right 
Femur 
87,190 3,463 4.0% 68,175 1,904 2.8% 
Pulse 
Sterile 
Corn Oil – 
Left Femur 
45,957 1,254 2.7% 43,081 813 1.9% 
 
 
 
By investigating these samples at a higher magnification, the distribution of Prx1 cells 
can be more easily recognized and compared. Figures 13 - 15 show representative 20x 
images of specific locations within the limb.  
Table 1: Quantitative Analysis of Baseline Tamoxifen and Sterile Corn Oil Response in Bone 
and Muscle Tissue 
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Figure 13: 20x Images of Periosteum. A. Continuous Tamoxifen, POD10. 
B. Tamoxifen Washout. C. No Tamoxifen. D. Pulse Sterile Corn Oil –Right 
Femur. E. Pulse Sterile Corn Oil – Left Femur. F. Washout Sterile Corn Oil.  
A 
F E D 
C B 100µm	
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Figure 14: 20x Images of Cortical Bone. A. Continuous Tamoxifen, 
POD10. B. Tamoxifen Washout. C. No Tamoxifen. D. Sterile Corn Oil 
Washout. E. Sterile Corn Oil Pulse 
A B C 
D E 
 
 
 																																						
A B C 
100µm	
100µm	
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Figure 15: 20x Images of Muscle. A. Continuous Tamoxifen, POD10. B. Tamoxifen 
Washout. C. No Tamoxifen. D. Pulse Sterile Corn Oil – Right Femur. E. Pulse Sterile Corn 
Oil – Left Femur. F. Washout Sterile Corn Oil 
A C
A 
B 
D E F 
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Figure 16: 10x Stitched Overview of Pre-Fracture Tamoxifen Injections, POD10. 
Fracture Model 
 
 Fracture surgery was utilized to investigate the role of trauma or injury in the 
recruitment of Prx1 positive cells to the fracture callus and nearby skeletal muscle. Again 
animals received Tamoxifen three days prior to surgery, continuously before and 
throughout fracture repair, or 30 day washout. Two time points were obtained, post-
operative day 10 and 14. As above, Prx1 cells appear red and the color blue displays 
DAPI. Figures 16-18 are 10x stitched overview images of the fracture model with callus 
formation. 
 																									
Callus 
1mm	
1mm	
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Callus 
Callus 
Figure 17: 10x Stitched Overviews of Continuous (Pre and Post-operative) 
Tamoxifen Injections, POD 10. A: Sample 1. B: Sample 2 	
A	
B	 1mm	
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Quantitative data was obtained by counting the total number of cells within the callus and 
muscle. Table 2 displays the cell counts for total nucleated cells, Prx1 cells, and then 
percentage of cells that are labeled Prx1 positive. Comparing the POD10 samples, the 
highest percentage of Prx1 cells was with the continuous Tamoxifen injections. The 
POD14 sample with Tamoxifen washout demonstrated an increase in percentage of Prx1 
cells. This could be due to a longer post-operative harvest date or potentially to the 
different Tamoxifen schedule. Independent of Tamoxifen injection, close to 50% of 
callus cells are derived from the Prx1 positive linage.  
 
 
 	
Figure 18: 10x Stitched Overview of Tamoxifen Washout, POD14 	
Callus 
1mm	
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Sample Callus Percentage 
of Prx1 Cells 
(%) 
Muscle Percentage 
of Prx1 
Cells (%) 
 Total 
Nucleated 
Cells 
Prx1 
Cells 
 Total 
Nucleated 
Cells 
Prx1 
Cells 
 
POD10, 
Pre-
Fracture 
Tamoxifen 
57,362 19,790 34.5% 41,907 2,556 6.1% 
POD10, 
Continuous 
Tamoxifen, 
Sample 1 
48,010 23,763 49.5% 32,582 2,183 6.7% 
POD10, 
Continuous 
Tamoxifen, 
Sample 2 
26,981 14,078 52.2% 28,993 2,349 8.1% 
POD14, 
Tamoxifen 
Washout 
29,164 18,005 61.7% 29,054 3,835 13.2% 
At 20x magnification, Prx1 cells can be more easily identified and traced throughout the 
fracture healing process. Figures 19-23 depict tissue specific sites within or near the 
fracture callus for comparison between the different fracture samples. These images 
demonstrated a similar pattern as the quantitative analysis of the overview images.  
 
 
 
 
 
 
 
Table 2: Quantitative Analysis of Fracture Healing in Callus and Surrounding Muscle for both POD 10 and 14 	
	30 
 
 
 
 
 
A 	 B 	 C	Figure 19: 20x Images of Periosteum. A. POD10, Continuous Tamoxifen. B. POD10, 
Pre-fracture Tamoxifen. C. POD14, Tamoxifen Washout.  	
Figure 20: 20x Images of Bone Forming. A. POD10, Continuous Tamoxifen. B. POD10, 
Pre-fracture Tamoxifen. C. POD14, Tamoxifen Washout.  	
A B C 
100µm	
100µm	
100µm	
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Figure 21: 20x Images of Chondrocytes. A+B. POD10, Continuous Tamoxifen. C. POD14, 
Tamoxifen Washout. D+E. POD10, Pre-fracture Tamoxifen. 	
A B C 
D E 
100µm	
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Figure 22: 20x Images of Muscle. A. POD10, Continuous Tamoxifen. B. POD10, 
Pre-fracture Tamoxifen. C. POD14, Tamoxifen Washout.  	
A B C 
Figure 23: 20x Images of Blood Vessels. A. POD10, Continuous Tamoxifen. B. 
POD10, Pre-fracture Tamoxifen. C. POD14, Tamoxifen Washout.  	
A B C 100µm	
100µm		
100µm	100µm	
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DBM Model 
 When evaluating the bone developmental ability of demineralized bone matrix, 
implants were placed onto the periosteal surface of the femur to evaluate the presence of 
Prx1 cells within ectopic bone formation. Similarly to the fracture model, these 
experiment mice were subjected to a unique schedule for Tamoxifen injections. DBM 
implants placed on the periosteal surface either received Tamoxifen 3 days prior to the 
DBM surgery, continuous Tamoxifen injections, or Tamoxifen washout. 10x stitched 
overview images of the DBM implants on the periosteal surface are displayed in figures 
24-26. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: 10x Stitched Overview of DBM Implant on Periosteum, Tamoxifen Washout, POD 8.  	
DBM 
Implant 
1mm	
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Figure 26: 10x Stitched Overview of DBM Implant on Periosteum, Tamoxifen 3 
days pre-DBM surgery, POD 8. 	
DBM 
Implant 
1mm	
1mm	
Figure 25: 10x Stitched Overview of DBM Implant on Periosteum, Continuous Tamoxifen, POD 8. 	
DBM 
Implant 
1 m	
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For the quantitative analysis portion of the DBM model, total cells were counted for both 
the implant as well as the surrounding skeletal muscle. The cell counts for total nucleated 
cells, Prx1 cells, and percentage of cells labeled Prx1 positive is shown in table 3. The 
largest percentage of Prx1 cells within the periosteal implants was the sample with the 
continuous Tamoxifen injections, followed by the washout and lastly the 3 day prior to 
DBM surgery injection. Interestingly, the muscle displayed again the highest percentage 
of Prx1 cells within the continuous Tamoxifen sample. 
 
Sample Implant Percentage 
of Prx1 
Cells (%) 
Muscle Percentage 
of Prx1 
Cells (%) 
 Total 
Nucleated 
Cells 
Prx1 
Cells 
 Total 
Nucleated 
Cells 
Prx1 
Cells 
 
Periosteal 
Implant, 
Tamoxifen 
Washout, POD8 
61,498 10,947 17.8% 28,899 2,283 7.9% 
Periosteal 
Implant, 
Continuous 
Tamoxifen, 
POD8 
63,071 15,326 24.3% 72,905 7,291 10.0% 
Periosteal 
Implant, 
Tamoxifen, 3 
days pre- DBM 
surgery, POD8 
34,562 6,947 20.1% 40,983 2,664 6.5% 
  
 
 
Table 3: Quantitative Analysis of Prx1 Cells within DBM Implant and Surrounding Skeletal Muscle	
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Along with the fracture model, these samples were explored at a magnification of 20x to 
further investigate and trace the Prx1 cells present in the DBM implant, and the 
surrounding tissues. Below, figures 27-32 reveal the close-up version of the tissue in 
order to attempt to understand where Prx1 cells might be recruited. 
 
 
 
 
 
 
 
 
 
Figure 27: 20x Images of Implant. A. Periosteal Implant, Tamoxifen Washout, POD8. B. 
Periosteal Implant, Continuous Tamoxifen, POD8. C. Periosteal Implant, Tamoxifen 3 days pre-
DBM surgery.  	
A 
C 
B 100µm	
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A B 
C 
Figure 28: 20x Images of Cortical Bone. A. Periosteal Implant, Tamoxifen Washout, POD8. B. 
Periosteal Implant, Continuous Tamoxifen, POD8. C. Periosteal Implant, Tamoxifen 3 days pre-DBM 
surgery.  	
100µm	
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Figure 29: 20x Images of Periosteum. A. Periosteal Implant, Tamoxifen Washout, POD8. B. 
Periosteal Implant, Continuous Tamoxifen, POD8. C. Periosteal Implant, Tamoxifen 3 days pre-
DBM surgery.  	
A B 
C 
100µm	
100µm	
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A B 
C 
Figure 30: 20x Images of Blood Vessel near Implant. A. Periosteal Implant, Tamoxifen Washout, POD8. B. 
Periosteal Implant, Continuous Tamoxifen, POD8. C. Periosteal Implant, Tamoxifen 3 days pre-DBM surgery.  	
100µm	
100µm	
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100µm	
Figure 31: 20x Images of Muscle. A. Periosteal Implant, Tamoxifen Washout, POD8. B. Periosteal Implant, 
Continuous Tamoxifen, POD8. C. Periosteal Implant, Tamoxifen 3 days pre-DBM surgery. D. Muscle Implant 
with BMP-2, Tamoxifen beginning POD16, POD24.  	
A B 
C 
100µm	
	41 
 
 
 
 
Tissue Specificity 
 In the interest of understanding how Prx1 is distributed throughout the various 
organs and tissues of the mouse, various organs including the spleen, liver, thigh fat, 
sternum/ribs, heart, aorta, brain, calvarium, forelimb, tibia, and kidney were harvested 
from a sterile corn oil washout sample. Through close inspection under 20x 
magnification, Prx1 cells were located within the tissue of the calvarium, aorta, brain, 
gonad fat, sternum/ribs, thigh fat, tibia, forelimb and spleen. No Prx1 expression could be 
identified within the heart or liver tissue. 
 
 
A B 
Figure 32: 20x Images of Additional Tissues A. Growth Plate. B. Fat near Implant 	
100µm	
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Figure 33: 10x Stitched Overview Images of Sterile Corn Oil Washout. A. Forelimb. B. Tibia. 	
A 
B 
1mm	
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qRT-PCR Analysis 
 qPCR was performed in order to explore the relative expression of Prx1 within 
several different tissues. As shown in figure 35, tissues including muscle, fat, and heart, 
were found to have the largest relative expression of Prx1. On the opposite side, we see 
that liver and kidney represent the smallest relative expression of Prx1. Interestingly, the 
tissues with the most Prx1 expression also have the largest standard deviations, meaning 
100µm	
Figure 34: 20x Tissue Specific Images of Sterile Corn Oil Washout. A: Kidney (10x stitched 
overview). B: Kidney. C: Brain (10x stitched overview). D: Brain. E: Calvarium (10x stitched 
overview). F: Calvarium. G: Aorta (10x stitched overview). H: Aorta. I: Thigh Fat (10x stitched 
overview). J: Thigh Fat. K: Sternum/Ribs (10x stitched overview). L: Sternum/Ribs. M: Heart (10x 
stitched overview). N: Heart. O: Spleen (10x stitched overview). P: Spleen. Q: Liver (10x stitched 
overview). 	
Q 
P
T 
O
S 
1mm	
1mm	
100µm	
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that there was great difference in Prx1 expression between the three different samples of 
each of those tissues. 
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Figure 35: qPCR Analysis of Prx1. This figure represents the relative gene expression 
normalized to the humerus and 18s rRNA of the same tissue. 
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DISCUSSION 
Baseline Response 
 Before Prx1 positive cells can be traced throughout ectopic bone formation and 
fracture calluses, the leakiness of the Cre system needs to be established as well as a 
baseline scenario with no trauma or implant. To complete this, controls received corn oil 
injections or no injections. Theoretically, no Prx1 cells should be labeled with corn oil, as 
the Cre should not translocate to the nucleus. A low level of Prx1 labeled cells were 
found in samples both with corn oil as well as no Tamoxifen injections, between 4-15%. 
In the right and left femurs of the pulse corn oil, there was a decreased percentage of Prx1 
labeled cells compared to the other treatments. The reason for this is unknown. However, 
labeled cells were identified in the bone marrow, growth plate, periosteum, and muscle. It 
should be noted that it can not be ruled out that there may have been accidental 
Tamoxifen exposure due to animal housing.  
  Both samples that received Tamoxifen revealed noticeably increased percentages 
of Prx1 labeled cells throughout the femur. At about 40 days after injection 21.2% of 
total nucleated cells in the bone tissues that were positive for Prx1 and the femur that 
sustained the washout Tamoxifen had a slightly increased in Prx1 labeled cells than the 
continuous Tamoxifen group. A similar pattern regarding the population of Prx1 labeled 
cells was observed in the muscle tissue. This could be expected as the washout 
Tamoxifen method labels the Prx1 cells as well as the derived lineages. Since harvest was 
completed after 30 days from the last injection, there was time for expansion and 
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differentiation of those previously labeled stem/progenitor cells. The continuous 
Tamoxifen injections composed of 14 total days with 6 injections.   
Effects of Callus Formation on Prx1 Recruitment 
 As discussed earlier, Prx1 cells are known to be a contributor to fracture healing 
as it has been discovered within both osteogenic and chondrogenic lineages in the callus 
(Murao et al., 2013). The fracture portion of this study permitted for investigation into 
how differing Tamoxifen schedules and harvest dates affect the recruitment of Prx1 cells. 
Two harvest time points, POD 10 and 14, and three different Tamoxifen procedures: pre-
fracture injections, washout, and continuous injections were used. As suspected, all 
samples showed some presence of Prx1 cells in and around the callus.  
 Post-operative harvest dates of 10 and 14 days were chosen to analyze calluses at 
different stages of healing. At POD10, most of the callus surrounding the fracture 
consists of cartilage, whereas POD14 has a callus that contains the beginnings of ossified 
bone.  
 Separate Tamoxifen injection schedules leads to labeling Prx1 cells at specific 
time points. The washout method tends to follow the lineages of stem cells that were 
labeled one month before surgery or harvest. Continuous injections of Tamoxifen 
attempts to identify expressing Prx1 cells through the process. Lastly, Tamoxifen 
injections prior to the fracture surgery target cells and their lineages that are recruited to 
the callus site during fracture repair, but not necessarily through the process.  
 Comparing the POD10 samples, the experimental mice that received continuous 
Tamoxifen injections displayed approximately half of their total nucleated cells to be 
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Prx1 positive within the callus. The sample given only pre-fracture injections of 
Tamoxifen possessed about one third of their total nucleated cells as Prx1 positive. The 
POD14 specimen represented a larger percentage of Prx1 positive cells, but this could be 
due to mainly two factors. First, the harvest date was four days later than the POD10 
samples and therefore could potentially have allowed for more expansion and 
differentiation. Also, it should be noted that the POD 14 received Tamoxifen washout. 
When establishing a baseline response, the washout method did lead to a higher 
percentage of labeling than the continuous injections.  Thus either a greater number of 
initial stem cells became labeled that expanded into their differentiated lineages or some 
fraction of committed cells derived from the initial stem cell expansion contributed to the 
bone formation of the callus. 
Effects of Ectopic Bone on Prx1 Recruitment 
 The recruitment of Prx1 derived cells to ectopic bone development was 
investigated. All periosteal implants were harvested on POD 8, but either received 
continuous Tamoxifen, Tamoxifen washout, or a single Tamoxifen injection 3 days prior 
to the DBM surgery. Similarly to the fracture model, these different Tamoxifen methods 
allowed for close tracking of the Prx1 positive cells during recruitment for ectopic bone 
growth.  
 When comparing the percentage of Prx1 positive cells in each scenario, it was 
interesting to see that the fracture callus had about 50% derived from Prx1, while the 
baseline samples possessed approximately 14% and the only about 25% contributed to 
ectopic bone formation. Given that the ectopic bone method was in the absence of injury, 
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it leads to possible conclusion that the trauma associated with the fracture model might be 
stimulating a larger recruitment of Prx1 cells to the injured area.  
 When counting cells in the surrounding skeletal muscle from the periosteal 
implant samples, the ectopic bone samples were noted to have an overall higher 
percentage of Prx1 positive cells than the POD10 fractures and baseline models. Prx1 
proportions noted above lead to a certain conclusion that Prx1 cells play a vital role in the 
osteogenic processes underlying ectopic bone formation. This response, however, is not 
focal to just the DBM implant, as Prx1 cells were found throughout the neighboring 
tissues.  
Tissue Specificity  
Previous studies have located Prx1 positive cells in the callus of a fractured 
mouse femur, but it was interesting to find Prx1 positive cells scattered throughout the 
surrounding skeletal muscle, endothelium of blood vessels, and adipose tissue (Murao et 
al., 2013). These results suggest the Prx1 cell is not restricted to the osteochondral 
progenitor cell originally thought. Mesenchymal stem cells are multipotent and able to 
differentiation into multiple lineages including osteoblasts, chondrocytes, myoblasts, and 
adipocytes. Our results indicated that Prx1 may actually be a multipotential mesenchymal 
stem cell.   
In the interest of understanding the specification of Prx1 as a mesenchymal stem 
cell, the distributed throughout the various organs and tissues of the mouse was 
investigated.  Through close inspection under 20x magnification, Prx1 cells were located 
within the tissue of the calvarium, aorta, brain, sternum/ribs, thigh fat, and spleen. No 
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Prx1 expression could be identified within the heart or liver tissue. During 
embryogenesis, Prx1 has been identified in the neural crest cells, which could explain the 
observation that Prx1 labeled cells were found in the calvarium and brain. As Prx1 had 
been discovered in blood vessels near both the fracture site and insertion of DBM matrix, 
it is not surprising to find it in the aorta and spleen.  
 During embryogenesis Prx1 is highly expressed in the limb bud cells. Our results 
show that Prx1 is found lining the periosteum in both the fore- and hindlimbs as well as 
the surrounding tissue. Very low levels were identified at the sternum/rib and these cells 
were restricted to the interface between rib and sternum. Taken together, it suggests that 
the restricted expression of Prx1 during embryogenesis persist through adult hood. And 
that Prx1 is a mesenchymal stem cell restricted to the appendicular skeleton.  
Future Directions 
 There are a few different directions that this research could diverge onto. First and 
foremost, it is vital to further investigate the sensitivity of the Cre recombinase system. 
From there, it would be intriguing to explore the presence of Prx1 cells. Why did we find 
Prx1 positive cells in the aorta, spleen, and blood vessels, but not the heart tissue? Further 
research should also focus on isolating the characterizing the Prx1 cells such as their 
transcriptome and signaling pathways. Once identified, these cells may be able to be 
manipulated and targeted for therapeutics.    	
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